Back to results
US 2024/0173300 A1Published application
Alpha-2-adrenergic receptor agonists for reducing redness and increasing whiteness in eyes and other ophthalmic purposes
AssigneeAllergan, Inc.
InventorMohammed Dibas
Life of this patent
Estimating the term…
Abstract
The disclosure provides, inter alia, methods of reducing eye redness and/or increasing eye whiteness using alpha-2-adrenergic receptor agonists.
Claims34
A method for reducing redness of an eye or increasing whiteness of an eye in an individual in need thereof, the method comprising administering to the individual a therapeutically effective amount of a compound of Formula I:
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.